Anti-Coronavirus Antibodies And Methods Of Use Read more about Anti-Coronavirus Antibodies And Methods Of Use US Application 63/080,351Filed on 2020-09-18
Anti-Coronavirus Antibodies And Methods Of Use Read more about Anti-Coronavirus Antibodies And Methods Of Use US Application 63/036,089Filed on 2020-06-08
Anti-Coronavirus Antibodies And Methods Of Use Read more about Anti-Coronavirus Antibodies And Methods Of Use US Application 63/030,530Filed on 2020-05-27
CHIKUNGUNYA VLP PRESENTING PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN EPITOPES AS A MALARIA VACCINE Read more about CHIKUNGUNYA VLP PRESENTING PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN EPITOPES AS A MALARIA VACCINE US Application 63/161,688Filed on 2021-03-16
Anti-Coronavirus Antibodies And Methods Of Use Read more about Anti-Coronavirus Antibodies And Methods Of Use US Application 62/987,313Filed on 2020-03-09
Nanoparticle Vaccines For Coronaviruses Read more about Nanoparticle Vaccines For Coronaviruses US Application 63/022,214Filed on 2020-05-08
NEWCASTLE DISEASE VIRUS-LIKE PARTICLE DISPLAYING PREFUSION-STABILIZED SARS-COV-2 SPIKE AND ITS USE Read more about NEWCASTLE DISEASE VIRUS-LIKE PARTICLE DISPLAYING PREFUSION-STABILIZED SARS-COV-2 SPIKE AND ITS USE US Application 63/140,250Filed on 2021-01-21
Novel Compositions Of Matter Comprising Stabilized Coronavirus Antigens And Their Use Read more about Novel Compositions Of Matter Comprising Stabilized Coronavirus Antigens And Their Use US Application 63/200,194Filed on 2021-02-19
REPLICATION-COMPETENT ADENOVIRUS TYPE 4 SARS-COV-2 VACCINES AND THEIR USE Read more about REPLICATION-COMPETENT ADENOVIRUS TYPE 4 SARS-COV-2 VACCINES AND THEIR USE US Application 63/138,221Filed on 2021-01-15
Engineered Influenza Neuraminidase Antigens Read more about Engineered Influenza Neuraminidase Antigens US Application 62/986,295Filed on 2020-03-06